Page 2 - Astrazeneca

UK marks Oxford/AstraZeneca Covid-19 vaccine's one-year anniversary

Our fight against COVID in the UK and around the world would not have been possible without the Oxford/AstraZeneca vaccine, said PM Boris Johnson

Oxford-AstraZeneca vaccine behind lower Covid deaths in UK, says expert

'If you look across Europe, with the rise in cases, there's also a corresponding lagged rise in deaths, but not in the UK,' says Dr Clive Dix, former chairman of the UK's Vaccine Task Force

AstraZeneca says its antibody drug Evusheld can fight Omicron variant

Evusheld is one of only two antibody therapies authorised for use that showed neutralising activity against Omicron and against all other variants of concern in these two studies.

Serum Institute on the up as Oxford study backs AstraZ booster for Omicron

Vaxzevria significantly boosts antibodies against the rapidly spreading variant of the coronavirus, shows study

AstraZeneca booster shot effective against Omicron: Oxford lab study

After a three-dose course of the vaccine, neutralising levels against Omicron were similar to those against the virus's Delta variant after two doses

'USFDA study shows Evusheld retains neutralising activity against Omicron'

The study was done independently by investigators at the US Food and Drug Administration (USFDA), Center for Biologics Evaluation and Research.

Billionaire Poonawalla family pledges $66 mn to Oxford for research campus

The pledge builds on the collaboration between Oxford University, AstraZeneca and SII, the world's largest maker of vaccines

Two doses of Covid vax induce lower antibody levels against Omicron: Study

Two doses of Pfizer AstraZeneca Covid vaccines generate lower levels of antibodies against the Omicron variant of coronavirus.

AstraZeneca in touch with Indian authorities for approval to Covid drug

The company said it has initiated engagements with Indian health authorities regarding its Covid prevention drug for people with weakened immune system

US FDA okays AstraZeneca's Covid antibody cocktail for immunocompromised

The US Food and Drug Administration (FDA) has granted emergency use authorisation to AstraZeneca's monoclonal antibody treatment for Covid-19 among people with weakened immune systems.

World's best-performing IPO in 2021 is a Korean bioscience firm

South Korean biopharmaceutical firm SK Bioscience's IPO raised $1.3 billion for the firm, which is a local Covid-19 vaccine-production partner with AstraZeneca Plc.

Next pandemic could be more lethal than Covid: AstraZeneca vaccine maker

Future pandemics could be even more lethal than Covid so the lessons learned from the pandemic must not be squandered, one of the creators of the Oxford-AstraZeneca vaccine said.

AstraZeneca blocks Advent's $7.6-bn buyout of Swedish Orphan Biovitrum

The UK drugmaker's opposition meant the offer fell short of the 90 per cent threshold needed for approval

Booster dose of six Covid vaccines safe, increases immunity: Lancet study

Six different COVID-19 boosters are safe and elicit strong immune response in people who have previously received a two-dose course of AstraZeneca or Pfizer vaccines.

Delta variant may have increased ability to evade vaccine immunity: Study

Vaccines are effective in decreasing hospitalization and deaths from Covid-19 infection but the emergence of viral variants of concern may diminish their efficacy, according to a recent study.

LIVE: Two SA returnees test Covid positive in Bengaluru; Omicron reaches UK

Two linked cases of the new Omicron coronavirus variant have been detected in Britain connected to travel to southern Africa, health minister Sajid Javid said on Saturday

AstraZeneca examining impact of new Covid-19 variant on vaccine

The company has also developed an antibody cocktail which can be used both to prevent and to treat Covid-19

SII resumes exports to COVAX, produces 1.25 bn Covishield doses this year

The first batches of Covishield left the SII manufacturing facility in Pune earlier today, for distribution to low- and middle-income countries

AstraZeneca chief credits Oxford vaccine with UK's Covid-19 fight

Soriot was speaking as his company unveiled a major state-of-the-art research and development facility in Cambridge

Covid-19: AstraZeneca opens research centre as UK builds science hub

Prince Charles will be on hand Tuesday when pharmaceutical company AstraZeneca opens a 1 billion-pound research centre near the University of Cambridge